Metropolitan Life Insurance CO Alnylam Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$127.18 - $173.91 $1 Million - $1.37 Million
-7,891 Closed
0 $0
Q4 2021

Jun 21, 2023
BUY
$159.56 - $209.29 $1.26 Million - $1.65 Million
7,891 New
7,891 $1.34 Million
Q4 2021

Mar 30, 2023
SELL
$159.56 - $209.29 $9,733 - $12,766
-61 Reduced 0.77%
7,891 $1.34 Million
Q4 2021

Feb 15, 2022
SELL
$159.56 - $209.29 $9,733 - $12,766
-61 Reduced 0.77%
7,891 $1.34 Million
Q3 2021

Jun 21, 2023
BUY
$169.75 - $207.73 $1.35 Million - $1.65 Million
7,952 New
7,952 $1.5 Million
Q3 2021

Mar 30, 2023
SELL
$169.75 - $207.73 $29,027 - $35,521
-171 Reduced 2.11%
7,952 $1.5 Million
Q3 2021

Nov 15, 2021
SELL
$169.75 - $207.73 $29,027 - $35,521
-171 Reduced 2.11%
7,952 $1.5 Million
Q2 2021

Jun 21, 2023
BUY
$128.63 - $176.89 $1.04 Million - $1.44 Million
8,123 New
8,123 $1.38 Million
Q2 2021

Mar 30, 2023
SELL
$128.63 - $176.89 $34,472 - $47,406
-268 Reduced 3.19%
8,123 $1.38 Million
Q2 2021

Aug 16, 2021
BUY
$128.63 - $176.89 $1.04 Million - $1.44 Million
8,115 Added 101437.5%
8,123 $1.38 Million
Q1 2021

Jun 26, 2023
BUY
$126.83 - $175.69 $1.06 Million - $1.47 Million
8,391 New
8,391 $1.18 Billion
Q1 2021

Mar 30, 2023
SELL
$126.83 - $175.69 $47,941 - $66,410
-378 Reduced 4.31%
8,391 $1.18 Million
Q1 2021

May 14, 2021
SELL
$126.83 - $175.69 $1.11 Million - $1.54 Million
-8,761 Reduced 99.91%
8 $1.19 Million
Q4 2020

Jun 22, 2023
BUY
$122.97 - $147.0 $1.08 Million - $1.29 Million
8,769 New
8,769 $1.14 Million
Q4 2020

Mar 30, 2023
SELL
$122.97 - $147.0 $21,027 - $25,137
-171 Reduced 1.91%
8,769 $1.14 Million
Q4 2020

Feb 16, 2021
SELL
$122.97 - $147.0 $21,027 - $25,137
-171 Reduced 1.91%
8,769 $1.14 Million
Q3 2020

Jun 26, 2023
BUY
$121.19 - $165.49 $1.08 Million - $1.48 Million
8,940 New
8,940 $1.3 Million
Q3 2020

Mar 30, 2023
SELL
$121.19 - $165.49 $17,087 - $23,334
-141 Reduced 1.55%
8,940 $1.3 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $17,087 - $23,334
-141 Reduced 1.55%
8,940 $1.3 Million
Q2 2020

Jun 26, 2023
BUY
$104.21 - $156.44 $946,331 - $1.42 Million
9,081 New
9,081 $1.34 Million
Q2 2020

Mar 30, 2023
BUY
$104.21 - $156.44 $244,685 - $367,321
2,348 Added 34.87%
9,081 $1.34 Million
Q2 2020

Aug 14, 2020
BUY
$104.21 - $156.44 $244,685 - $367,321
2,348 Added 34.87%
9,081 $1.35 Million
Q1 2020

Jul 12, 2023
BUY
$93.12 - $133.99 $626,976 - $902,154
6,733 New
6,733 $732,000
Q1 2020

Mar 30, 2023
SELL
$93.12 - $133.99 $9,218 - $13,265
-99 Reduced 1.45%
6,733 $732,000
Q1 2020

May 15, 2020
SELL
$93.12 - $133.99 $9,218 - $13,265
-99 Reduced 1.45%
6,733 $733,000
Q4 2019

Jul 12, 2023
BUY
$74.51 - $124.23 $509,052 - $848,739
6,832 New
6,832 $786,000
Q4 2019

Mar 30, 2023
SELL
$74.51 - $124.23 $8,792 - $14,659
-118 Reduced 1.7%
6,832 $786,000
Q4 2019

Feb 14, 2020
SELL
$74.51 - $124.23 $8,792 - $14,659
-118 Reduced 1.7%
6,832 $787,000
Q3 2019

Jul 12, 2023
BUY
$70.9 - $87.82 $492,755 - $610,349
6,950 New
6,950 $558,000
Q3 2019

Mar 30, 2023
BUY
$70.9 - $87.82 $37,931 - $46,983
535 Added 8.34%
6,950 $558,000
Q3 2019

Nov 14, 2019
BUY
$70.9 - $87.82 $37,931 - $46,983
535 Added 8.34%
6,950 $559,000
Q2 2019

Jul 12, 2023
BUY
$65.86 - $92.79 $422,491 - $595,247
6,415 New
6,415 $465,000
Q2 2019

Mar 30, 2023
SELL
$65.86 - $92.79 $9,352 - $13,176
-142 Reduced 2.17%
6,415 $465,000
Q2 2019

Aug 14, 2019
SELL
$65.86 - $92.79 $9,352 - $13,176
-142 Reduced 2.17%
6,415 $465,000
Q1 2019

Jul 13, 2023
BUY
$72.76 - $93.45 $477,087 - $612,751
6,557 New
6,557 $612,000
Q1 2019

Mar 30, 2023
BUY
$72.76 - $93.45 $477,087 - $612,751
6,557 New
6,557 $612,000
Q1 2019

May 16, 2019
SELL
$72.76 - $93.45 $583,244 - $749,095
-8,016 Reduced 55.01%
6,557 $612,000
Q1 2019

May 15, 2019
BUY
$72.76 - $93.45 $599,324 - $769,747
8,237 Added 130.0%
14,573 $495,000
Q4 2018

Jul 13, 2023
BUY
$62.67 - $88.33 $397,077 - $559,658
6,336 New
6,336 $461,000
Q4 2018

Feb 14, 2019
SELL
$62.67 - $88.33 $1,190 - $1,678
-19 Reduced 0.3%
6,336 $462,000
Q3 2018

Jul 13, 2023
BUY
$87.52 - $122.67 $556,189 - $779,567
6,355 New
6,355 $556 Million
Q3 2018

Nov 14, 2018
SELL
$87.52 - $122.67 $12,865 - $18,032
-147 Reduced 2.26%
6,355 $556,000
Q2 2018

Aug 15, 2018
BUY
$88.31 - $107.8 $45,391 - $55,409
514 Added 8.58%
6,502 $0
Q1 2018

May 15, 2018
BUY
$115.92 - $148.54 $9,737 - $12,477
84 Added 1.42%
5,988 $0
Q4 2017

Feb 15, 2018
BUY
$114.49 - $139.98 $40,300 - $49,272
352 Added 6.34%
5,904 $750,000
Q3 2017

Nov 14, 2017
BUY
$72.53 - $118.27 $43,518 - $70,962
600 Added 12.12%
5,552 $652,000
Q2 2017

Aug 14, 2017
BUY
N/A
4,952
4,952 $395,000

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email